Clinical trial
Safety and Pharmacodynamic Study of CD-NP
NCT00482937 · Nile Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00482937 |
|---|---|
| Title | Safety and Pharmacodynamic Study of CD-NP |
| Official title | A Phase I, Single Ascending Dose Trial to Examine the Safety and Pharmacodynamic Effects of CD-NP |
| Lead sponsor | Nile Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | CD-NP |
| Enrollment | 22 |
| Start date | Jan 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jun 6, 2007 |
| Last update posted | Jun 6, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: